Literature DB >> 12106610

Modulation of tamoxifen-induced apoptosis by peripheral benzodiazepine receptor ligands in breast cancer cells.

Renate Strohmeier1, Marc Roller, Nicole Sänger, Rainald Knecht, Herbert Kuhl.   

Abstract

The peripheral benzodiazepine receptor (PBR), an integral protein of the mitochondrial membrane, is involved in the formation of mitochondrial permeability transition (MPT) pores. The opening of the MPT-leading to the dissipation of the inner-mitochondrial transmembrane potential (deltapsi(m))-is considered to be an early apoptotic event. Therefore, we investigated the effect of the high-affinity PBR ligands Ro5-4684 and PK 11195 on tamoxifen (TAM)-induced apoptosis in MCF-7 and BT-20 breast cancer cell lines. Application of 100 nM TAM led to induction of apoptosis in both cell lines. Estrogene receptor (ER)-positive MCF-7 cells arrested in G(2/M) by TAM treatment showed no general dissipation of deltapsi(m), but reduction of deltapsi(m) was observed in a population of cells with high deltapsi(m). In ER-negative BT-20 cells TAM treatment induced no arrest of the cell cycle but dissipation of deltapsi(m). In both cell lines, nanomolar concentrations of the PBR ligands, which showed minor pro-apoptotic action themselves, reduced TAM-induced decrease of deltapsi(m) and apoptosis. In MCF-7 cells, a reduction of bcl-2 protein expression by TAM treatment was abolished by a combination of TAM with PBR ligands. Bax protein expression in BT-20 cells showed a significant increase in TAM-treated cells after 24hr but was not increased when treated with TAM and PBR ligands. From these findings, we concluded that binding of PBR ligands in nanomolar concentrations protects cells against apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12106610     DOI: 10.1016/s0006-2952(02)01059-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  4'-Chlorodiazepam Protects Mitochondria in T98G Astrocyte Cell Line from Glucose Deprivation.

Authors:  Eliana Baez; Gina Paola Guio-Vega; Valentina Echeverria; Daniel Andres Sandoval-Rueda; George E Barreto
Journal:  Neurotox Res       Date:  2017-04-13       Impact factor: 3.911

Review 2.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.

Authors:  Rainer Rupprecht; Vassilios Papadopoulos; Gerhard Rammes; Thomas C Baghai; Jinjiang Fan; Nagaraju Akula; Ghislaine Groyer; David Adams; Michael Schumacher
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

3.  Effects of celecoxib and ly117018 combination on human breast cancer cells in vitro.

Authors:  Klaus H Baumann; Elmar Klusmeier; Isabel Eggemann; Silke Reinartz; Achim Almeroth; Mathias Kalder; Uwe Wagner
Journal:  Breast Cancer (Auckl)       Date:  2009-04-07

4.  Microglial Pro-Inflammatory and Anti-Inflammatory Phenotypes Are Modulated by Translocator Protein Activation.

Authors:  Eleonora Da Pozzo; Chiara Tremolanti; Barbara Costa; Chiara Giacomelli; Vladimir M Milenkovic; Stefanie Bader; Christian H Wetzel; Rainer Rupprecht; Sabrina Taliani; Federico Da Settimo; Claudia Martini
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923

5.  Mitochondria modulatory effects of new TSPO ligands in a cellular model of tauopathies.

Authors:  Amandine Grimm; Imane Lejri; François Hallé; Martine Schmitt; Jürgen Götz; Frederic Bihel; Anne Eckert
Journal:  J Neuroendocrinol       Date:  2019-10-13       Impact factor: 3.627

6.  The 1,4-benzodiazepine Ro5-4864 (4-chlorodiazepam) suppresses multiple pro-inflammatory mast cell effector functions.

Authors:  Omid Sascha Yousefi; Thomas Wilhelm; Karin Maschke-Neuß; Marcel Kuhny; Christian Martin; Gerhard J Molderings; Felix Kratz; Bernd Hildenbrand; Michael Huber
Journal:  Cell Commun Signal       Date:  2013-02-20       Impact factor: 5.712

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.